Pediatrics pharmacovigilance: need of a new sub-unit

Authors

  • Rakesh C. Chaurasia Department of Pharmacology, M.L.N. Medical College, Allahabad 211002, India

Keywords:

Adverse Drug Reactions, Pharmacoenvironmentology, WHO-EMLc

Abstract

Pharmacovigilance is a new discipline of pharmacology concerned with adverse drug reaction (ADR) monitoring. Being an emerging section, it gains widespread global popularity within a short span of time. Pediatrics is very special branch of medical science deals with innocent aspect of growing life. As most of their body physiology are varies in accordance to age, therefore ADRs detection needs special attention.

References

Pharmacovigilance. Available at http://en.wikipedia.org/wiki/Pharmacovigilance. Accessed 9 March 2011.

World Health Organization. Pharmacovigilance. Available at http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/index.html. Accessed 9 March 2011.

Rajaseharan A. Pharmacovigilance: History, Need and Definition. Annual National Conference of the Society of Pharmacovigilance, India, SoPICon 2008,2-6.

World Health Organization. The WHO Model Lists of Essential Medicines-Model list for children. Available at http://www.who.int/medicines/publications/essentialmedicines/en/. Accessed 9 March 2011.

Chaurasia RC. Rational phamacotherapeutic approach in therapeutic practices. Paper presentation at International conference on Rational use of Medicines, 27 November 2010, at LHMC, New Delhi, India.

Downloads

Published

2017-02-04

How to Cite

Chaurasia, R. C. (2017). Pediatrics pharmacovigilance: need of a new sub-unit. International Journal of Basic & Clinical Pharmacology, 1(2), 116–117. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1408

Issue

Section

Educational Forum